NCT06512753Status unknown
The Effectiveness of Hydroxychloroquine Versus Methotrexate in the Treatment of Lichen Planopilaris in Routine Clinical Care: a Patient Preference Trial
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Status unknown
- Declared phase
- No phase declared
- Sponsor
- Erasmus Medical Center
- Participants (registry)
- 56
- Start
- July 2024
- Primary completion
- July 2026
- Study completion
- July 2026
- Last registry update
- July 2024
- Countries
- Netherlands
Conditions studied: Lichen Planopilaris, Cicatricial Alopecia
Interventions: Hydroxychloroquine, Methotrexate
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.